Applied DNA Sciences (NASDAQ:APDN) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a research note published on Tuesday. The brokerage issued a hold rating on the technology company’s stock.

Separately, HC Wainwright reduced their price objective on shares of Applied DNA Sciences from $40.00 to $30.00 and set a buy rating for the company in a research note on Friday, February 9th.

Applied DNA Sciences Price Performance

Shares of Applied DNA Sciences stock opened at $3.60 on Tuesday. Applied DNA Sciences has a 1 year low of $3.27 and a 1 year high of $37.20. The company has a market capitalization of $3.06 million, a P/E ratio of -0.33 and a beta of 0.26. The business has a 50-day moving average of $7.90 and a two-hundred day moving average of $12.08.

Applied DNA Sciences (NASDAQ:APDN) last announced its earnings results on Thursday, February 8th. The technology company reported ($1.80) earnings per share for the quarter, topping analysts’ consensus estimates of ($6.20) by $4.40. The firm had revenue of $0.89 million during the quarter, compared to analyst estimates of $0.70 million. Applied DNA Sciences had a negative net margin of 80.14% and a negative return on equity of 159.93%. On average, equities analysts anticipate that Applied DNA Sciences will post -12.6 EPS for the current fiscal year.

Institutional Investors Weigh In On Applied DNA Sciences

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned about 0.72% of Applied DNA Sciences at the end of the most recent quarter. 22.22% of the stock is currently owned by institutional investors.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.